Provisio Medical Technologies Corp

Provisio Medical Technologies Corp has raised $9.8M in total funding. The most recent round was Seed.

Provisio Medical Technologies Corp is headquartered in San Diego, CA.

Provisio Medical Technologies Corp. is dedicated to developing innovative solutions for Peripheral Artery Disease, including an automated, integrated smart-catheter technology called the SLT Platform which includes the SLT FLOW, the world's first and only catheter-based volumetric blood flow measurement intra-procedurally.

Peripheral Artery Disease affects 200M people with a mortality rate worse than most cancers, yet current diagnostics (angiograms and traditional IVUS) underestimate vessel size, are underused, and can't measure blood flow during a procedure.

Provisio is developing the SLT Platform, an automated smart-catheter system designed to size, map, confirm, and assess treatment success, including SLT FLOW for intra-procedural volumetric blood flow measurement.

The site claims SLT FLOW is the world's first and only catheter-based volumetric blood flow measurement, cites FDA Breakthrough Device Designation as pending, and notes a new ICD-10 code it says no competitor can bill.

Founded by Dr. S. Eric Ryan, a former Volcano Corporation VP, Provisio Medical develops intravascular ultrasound smart-catheter technology and has raised tens of millions in venture funding, including backing tied to MedTech Innovator.